| Laurel Ridge Center | |
| 75 Hickle Street, Uniontown, Pennsylvania 15401 | |
| (724) 437-9871 | |
| Name | Laurel Ridge Center |
|---|---|
| Location | 75 Hickle Street, Uniontown, Pennsylvania |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 61 |
| Occupancy Rate | 57.7% |
| Medicare ID (CCN) | 395243 |
| Legal Business Name | 75 Hickle Street Operations Llc |
| Ownership Type | For Profit - Partnership |
| NPI Number | 1033151584 |
| Organization Name | GMA-UNIONTOWN INC |
| Doing Business As | LAUREL RIDGE CENTER |
| Address | 75 Hickle St, Uniontown, PA 15401 |
| Phone Number | 724-437-9871 |
News Archive
Field trials and genetic studies have shown that a new variety of broccoli reliably yields higher levels of a health-promoting compound.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the Company has received U.S. Food and Drug Administration (FDA) approval to market mesna injection (mesna), a prophylactic agent used to reduce the incidence of hemorrhagic cystitis caused by ifosfamide chemotherapy.
A new Jeff Kagan Report & Comment discusses Life After Stroke. Jeff Kagan has been one of the most well-known voices in the wireless and telecom industry for the past 25 years. Five years ago he had a stroke that changed his life and took him out of the game for a while.
Heart damage due to blocked arteries remains the leading cause of disease and death in the Western world, but a Florida State University College of Medicine researcher is helping to open new pathways toward treating the problem.
› Verified 5 days ago
| NPI Number | 1750563060 |
| Organization Name | 75 HICKLE STREET OPERATIONS LLC |
| Doing Business As | LAUREL RIDGE CENTER |
| Address | 75 Hickle St, Uniontown, PA 15401 |
| Phone Number | 724-437-9871 |
News Archive
Field trials and genetic studies have shown that a new variety of broccoli reliably yields higher levels of a health-promoting compound.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the Company has received U.S. Food and Drug Administration (FDA) approval to market mesna injection (mesna), a prophylactic agent used to reduce the incidence of hemorrhagic cystitis caused by ifosfamide chemotherapy.
A new Jeff Kagan Report & Comment discusses Life After Stroke. Jeff Kagan has been one of the most well-known voices in the wireless and telecom industry for the past 25 years. Five years ago he had a stroke that changed his life and took him out of the game for a while.
Heart damage due to blocked arteries remains the leading cause of disease and death in the Western world, but a Florida State University College of Medicine researcher is helping to open new pathways toward treating the problem.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Field trials and genetic studies have shown that a new variety of broccoli reliably yields higher levels of a health-promoting compound.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the Company has received U.S. Food and Drug Administration (FDA) approval to market mesna injection (mesna), a prophylactic agent used to reduce the incidence of hemorrhagic cystitis caused by ifosfamide chemotherapy.
A new Jeff Kagan Report & Comment discusses Life After Stroke. Jeff Kagan has been one of the most well-known voices in the wireless and telecom industry for the past 25 years. Five years ago he had a stroke that changed his life and took him out of the game for a while.
Heart damage due to blocked arteries remains the leading cause of disease and death in the Western world, but a Florida State University College of Medicine researcher is helping to open new pathways toward treating the problem.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.66 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 13.61 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 51.28 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 5.16 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.62 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 6.29 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.87 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 94.83 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 11.73 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 84.46 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.74 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 43.5 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 16.15 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 15.94 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.58 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 75.95 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 84.68 | 82.93 |
News Archive
Field trials and genetic studies have shown that a new variety of broccoli reliably yields higher levels of a health-promoting compound.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the Company has received U.S. Food and Drug Administration (FDA) approval to market mesna injection (mesna), a prophylactic agent used to reduce the incidence of hemorrhagic cystitis caused by ifosfamide chemotherapy.
A new Jeff Kagan Report & Comment discusses Life After Stroke. Jeff Kagan has been one of the most well-known voices in the wireless and telecom industry for the past 25 years. Five years ago he had a stroke that changed his life and took him out of the game for a while.
Heart damage due to blocked arteries remains the leading cause of disease and death in the Western world, but a Florida State University College of Medicine researcher is helping to open new pathways toward treating the problem.
› Verified 5 days ago
Uniontown Healthcare And Rehabilitation Center Location: 129 Franklin Avenue, Uniontown, Pennsylvania 15401 Phone: (724) 439-5700 | |
Lafayette Manor, Inc Location: 147 Lafayette Manor Road, Uniontown, Pennsylvania 15401 Phone: (724) 430-4848 | |
Bella Healthcare Center Location: 410 Terrace Drive, Uniontown, Pennsylvania 15401 Phone: (724) 438-6000 |